The second GAMRIC conference has started this morning. We are very excited to welcome the participants to Lisbon, Portugal to discuss the latest innovations in the fight against AMR. You can follow along on our social media channels using the hashtag #GAMRIC2026.

Science & Research

The first part of the Bundibugyo ebolavirus vaccine series took place last week and is now available for replay on ESCMID Media for those that missed the live event. Be sure to also register for the next part taking place 30 September covering the BDBV vaccine development pipeline.

You can now register for the the 3rd UEMS European Examination in Medical Microbiology taking place 28 November. This joint exam between UEMS and ESCMID aligns with the UEMS Core Training Programme for Medical Microbiology, European best practice guidelines, and key recent publications from leading scientific journals. Registration closes 20 October.

Education

Join the Emerging Infections Subcommittee who will provide an accessible introduction to emerging infectious diseases. Infectious disease trainees and early-career professionals will explore why and how infectious threats emerge, how they are detected and contained, and how clinicians respond.

This course aims to provide participants with a deeper understanding of the ethical issues surrounding antimicrobial stewardship, including those related to One Health topics and infection control practices. This course is part of the AMS Certificate Programme but has open spaces available for additional participants.

Congress & Events

Secure your accommodation in Stockholm through Congrex, the official accommodation partner for ESCMID Global 2027. A wide range of hotels are available at exclusive congress rates, with options to suit every budget. Book early to secure your preferred hotel on the ESCMID website.

Guidelines & Journals

In this fourth collaboration between SIDP’s Breakpoints and ESCMID’s Communicable podcasts, hosts Erin McCreary and Josh Davis are joined by Steve Webb, REMAP-CAP investigator and 'godfather of adaptive trial design', and Steve Tong, esteemed clinical trialist, to discuss the REMAP-CAP results on oseltamivir for critically ill patients.

The Bundibugyo virus disease outbreak in the Democratic Republic of the Congo continues to expand, with 7,475 confirmed cases and 3,605 deaths reported. In Europe, West Nile virus transmission is expanding, with 1,482 locally acquired cases across 16 countries. Measles transmission persists globally, notably with outbreaks in the Americas, Africa, and Europe. Denmark has reported six hospitalised cases of severe iatrogenic botulism linked to cosmetic injections. A mumps outbreak involving student-athletes is under investigation at San Diego State University. Thailand recorded three cases of severe fever with thrombocytopenia syndrome, and Germany reported a cluster of eight locally acquired malaria cases linked to Frankfurt Airport.

Sex differences in surgically treated left-sided infective endocarditis: Results from the international, prospective, multicentre BESOS study

Eritoran and Apremilast in hospitalised patients with COVID-19: the REMAP-CAP Immune Modulation-2 Domain